Wednesday 23rd August, 2017
69 ℉ | 93 ℉Raleigh

Durham company sets terms of $69M IPO

Business Journal - Tuesday 20th June, 2017

Durham-based Dova Pharmaceuticals disclosed in a filing with the SEC on Monday that it will offer 4,062,500 shares of common stock in its initial public offering, at a price of between $15 and $17 per share. The company has applied to list its stock on the Nasdaq exchange under the ticker symbol DOVA.

Dova ' formed in March 2016 ' acquired its drug candidate avatrombopag from Eisai that same month. After completing a pair of successful Phase 3 clinical trials, the company said in the filing...

Read More

More North Carolina State News

Access More
Loading data...




Sign up for North Carolina State News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!